Celltrion headquarters in Incheon / Courtesy of Celltrion
Celltrion, a Korean bio firm, said Thursday it will accelerate its shareholder-friendly policies, including the issuance of bonus shares.
The bio firm will issue 0.05 bonus shares per existing share, according to its regulatory filing, an amount equivalent to around 10,920,000 shares.
The company also plans to buy back some 550,000 shares, worth around 100 billion won ($66.4 million). This will bring the total amount of stocks repurchased by the company to some 2 trillion won this year, the company said.
The bio firm added that its largest shareholder, Celltrion Holdings, plans to acquire round 100 billion won worth of shares of Celltrion.
